Search

Clinical Research

Iovance Biotherapeutics Announces Six Abstracts to be Presented at the Upcoming 2017 SITC Annual Meeting

Iovance Biotherapeutics Announces Six Abstracts to be Presented at the Upcoming 2017 SITC Annual Meeting  GuruFocus.comCalifornia State Teachers Retirement System Takes $688000 Position in Iovance Biotherapeutics Inc (NASDAQ:IOVA)  The Ledger GazetteIovance Biotherapeutics (IOVA) & Affymetrix (AFFX) Critical Review  StockNewsTimesFull coverage https://www.gurufocus.com/news/610133

Advertisements

Pfizer departure nears

Pfizer departure nears  Plattsburgh Press RepublicanFull coverage http://www.pressrepublican.com/news/local_news/pfizer-departure-nears/article_7d7abd14-9279-5ce9-bd59-9d6842c4955b.html

Roche Licenses Ionis’ Antisense HD Therapy Following Groundbreaking Trial

Roche Licenses Ionis’ Antisense HD Therapy Following Groundbreaking Trial  Genetic Engineering & Biotechnology NewsIonis Pharma licenses IONIS-HTT Rx to Roche following successful phase 1/2a study in patients with Huntington’s …  pharmabiz.comFull coverage https://www.genengnews.com/gen-news-highlights/roche-licenses-ionis-antisense-hd-therapy-following-groundbreaking-trial/81255265

ACADIA Pharmaceuticals Announces Appointment of Damien McDevitt, Ph.D., as Senior Vice President, Corporate …

ACADIA Pharmaceuticals Announces Appointment of Damien McDevitt, Ph.D., as Senior Vice President, Corporate …  NB HerardFull coverage https://nbherard.com/business/acadia-pharmaceuticals-announces-appointment-of-damien-mcdevitt-ph-d-as-senior-vice-president-corporate-development/36687

BREAKTHROUGH: First Ever Treatment Discovered For Huntington’s Disease

BREAKTHROUGH: First Ever Treatment Discovered For Huntington’s Disease  Science TrendsHuntington’s Disease: Experimental Drug Marks Huge Breakthrough In First Human Trial  Tech TimesFull coverage https://sciencetrends.com/breakthrough-first-ever-treatment-discovered-huntingtons-disease/

Pfizer breast cancer drug superior to chemotherapy in late stage study

Pfizer breast cancer drug superior to chemotherapy in late stage study  ReutersFull coverage https://www.reuters.com/article/us-pfizer-cancer/pfizer-breast-cancer-drug-superior-to-chemotherapy-in-late-stage-study-idUSKBN1E21R5

PaxVax’s cholera vaccine can control outbreaks quickly

PaxVax’s cholera vaccine can control outbreaks quickly  InfosurhoySingle-dose cholera vaccine could provide faster protection, study finds  Homeland Preparedness NewsFull coverage http://www.infosurhoy.com/cocoon/saii/xhtml/en_GB/news/paxvaxs-cholera-vaccine-can-control-outbreaks-quickly/

Pfizer breast cancer drug superior to chemotherapy in late stage study

Pfizer breast cancer drug superior to chemotherapy in late stage study  ReutersFull coverage https://www.reuters.com/article/us-pfizer-cancer/pfizer-breast-cancer-drug-superior-to-chemotherapy-in-late-stage-study-idUSKBN1E21R5

Percutaneous femoropopliteal bypass system receives IDE approval

Percutaneous femoropopliteal bypass system receives IDE approval  HealioFull coverage https://www.healio.com/cardiac-vascular-intervention/peripheral/news/online/%7B833773f8-a59c-4319-b60f-0545cad824f3%7D/percutaneous-femoropopliteal-bypass-system-receives-ide-approval

Create a free website or blog at WordPress.com.

Up ↑

%d bloggers like this: